EUVIMEDEUVIMED entdecken
Open Access

Receptor-Targeted Peptide Conjugates Based on Diphosphines Enable Preparation of 99m Tc and 188 Re Theranostic Agents for Prostate Cancer

Truc T Pham, Ingebjørg N Hungnes, Charlotte Rivas, Julie Cleaver, George Firth, Philip J Blower, Jane Sosabowski, Gary J R Cook, Lefteris Livieratos, Jennifer D Young, Paul G Pringle, Michelle T Ma

Journal of Nuclear Medicine · 2024

DOI: 10.2967/jnumed.124.267450 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nuclear Medicine, 2024. Verfasst von Truc T Pham und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Bioengineering and Imaging Sciences, St. Thomas' Hospital, King's College London, London, United Kingdom; truc.pham@kcl.ac.uk michelle.ma@k…. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Rhenium, Technetium, Radioisotopes. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Cancer Research UK, Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsRheniumTechnetiumRadioisotopesMaleMiceAnimalsHumansCell Line, TumorTissue DistributionGlutamate Carboxypeptidase IIAntigens, SurfaceRadiopharmaceuticalsTheranostic NanomedicinePeptidesPrecision Medicine

Stichwörter der Autor:innen

188Re99mTcPSMASPECTphosphine

Substanzen

RheniumTechnetiumRadioisotopesRhenium-188Glutamate Carboxypeptidase IIAntigens, SurfaceRadiopharmaceuticalsPeptides

Autor:innen und Institutionen

  • School of Bioengineering and Imaging Sciences, St. Thomas' Hospital, King's College London, London, United Kingdom; truc.pham@kcl.ac.uk michelle.ma@kcl.ac.uk.
  • School of Bioengineering and Imaging Sciences, St. Thomas' Hospital, King's College London, London, United Kingdom.
  • Centre for Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, John Vane Science Centre, Queen Mary University of London, London, United Kingdom.
  • Department of Nuclear Medicine, Guy's and St. Thomas' Hospitals NHS Foundation Trust, Guy's Hospital, London, United Kingdom; and.
  • School of Chemistry, University of Bristol, Bristol, United Kingdom.

Förderung

  • Cancer Research UK
  • Wellcome Trust

Zitieren

APA

Pham, T. T., Hungnes, I. N., Rivas, C., Cleaver, J., Firth, G., Blower, P. J., Sosabowski, J., Cook, G. J. R., Livieratos, L., Young, J. D., Pringle, P. G., & Ma, M. T. (2024). Receptor-Targeted Peptide Conjugates Based on Diphosphines Enable Preparation of 99m Tc and 188 Re Theranostic Agents for Prostate Cancer. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.124.267450

Vancouver

Pham TT, Hungnes IN, Rivas C, Cleaver J, Firth G, Blower PJ, et al. Receptor-Targeted Peptide Conjugates Based on Diphosphines Enable Preparation of 99m Tc and 188 Re Theranostic Agents for Prostate Cancer. Journal of Nuclear Medicine. 2024. doi:10.2967/jnumed.124.267450

BibTeX
@article{Pham2024,
  author = {Pham, Truc T and Hungnes, Ingebjørg N and Rivas, Charlotte and Cleaver, Julie and Firth, George and Blower, Philip J and Sosabowski, Jane and Cook, Gary J R and Livieratos, Lefteris and Young, Jennifer D and Pringle, Paul G and Ma, Michelle T},
  title = {Receptor-Targeted Peptide Conjugates Based on Diphosphines Enable Preparation of 99m Tc and 188 Re Theranostic Agents for Prostate Cancer},
  journal = {Journal of Nuclear Medicine},
  year = {2024},
  doi = {10.2967/jnumed.124.267450}
}
Kostenlos starten →